Date of dispatch of this notice: 13/07/2020
Expire date: 14/08/2020
External Reference: 2020-234457
TED Reference: 2020/S 136-334989
Contract notice
Information
Published
Contract notice
Contract notice
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
Education Procurement Service (EPS)
IE 6609370 G
University of Limerick
Castletroy
Co.Limerick
IE
Contact person:
Linda Maher
Telephone:
+353 61233715
E-mail:
linda.maher@ul.ie
Internet address(es):
Main address:
http://www.educationprocurementservice.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/87073
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=170425&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
Tenders or requests to participate must be submitted
electronically via:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=170425&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Education
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
LEE882C - NUI Galway - Preclinical Evaluation of Hydrobloc
II.1.2)
Main CPV code
73110000
-
Research services
II.1.3)
Type of contract
Services
II.1.4)
Short description
NUI Galway wishes to source and appoint a suitably qualified and experienced Contract Research Organisation (CRO) to support the research and development requirements for their Preclinical Evaluation of Hydrobloc.
The goal of the project is to develop a novel stabilised gel for the treatment of chronic pain. Specifically, this 12-month project aims to develop the Hydrobloc technology and complete all necessary safety and efficacy testing in order for this novel medical device to be ready for first in human trials.
This tender is split into three lots as follows;
• Lot 1: Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
• Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
• Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993).
The goal of the project is to develop a novel stabilised gel for the treatment of chronic pain. Specifically, this 12-month project aims to develop the Hydrobloc technology and complete all necessary safety and efficacy testing in order for this novel medical device to be ready for first in human trials.
This tender is split into three lots as follows;
• Lot 1: Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
• Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
• Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993).
II.1.5)
Estimated total value
Value excluding VAT: 28000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
yes
Tenders may be submitted for
all lots
II.2)
Description
II.2.1)
Title
Lot 1 - Pre-Clinical Efficacy Studies
Lot No:
1
II.2.2)
Additional CPV code(s)
71620000
-
Analysis services
71900000
-
Laboratory services
73000000
-
Research and development services and related consultancy services
73111000
-
Research laboratory services
73210000
-
Research consultancy services
73300000
-
Design and execution of research and development
II.2.3)
Place of performance
Main site or place of performance:
NUI Galway
II.2.4)
Description of the procurement
Pre-Clinical Efficacy Studies in a model of Osteoarthritis.
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
12
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2)
Description
II.2.1)
Title
Lot 2 - Pre-Clinical Efficacy Study
Lot No:
2
II.2.2)
Additional CPV code(s)
71620000
-
Analysis services
71900000
-
Laboratory services
73000000
-
Research and development services and related consultancy services
73111000
-
Research laboratory services
73210000
-
Research consultancy services
73300000
-
Design and execution of research and development
II.2.3)
Place of performance
Main site or place of performance:
NUI Galway
II.2.4)
Description of the procurement
Lot 2: Pre-Clinical Efficacy Study in a model of Neuropathic Pain.
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
12
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2)
Description
II.2.1)
Title
Lot 3 - Pre-Clinical Biocompatibility and Safety Studies
Lot No:
3
II.2.2)
Additional CPV code(s)
71620000
-
Analysis services
71900000
-
Laboratory services
73000000
-
Research and development services and related consultancy services
73111000
-
Research laboratory services
73210000
-
Research consultancy services
73300000
-
Design and execution of research and development
II.2.3)
Place of performance
Main site or place of performance:
NUI Galway
II.2.4)
Description of the procurement
Lot 3: Pre-Clinical Biocompatibility and Safety Studies (in compliance with ISO 10993)
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
12
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section III: Legal, economic, financial and technical information
III.1)
Conditions for participation
III.1.1)
Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
Please see RFT document for further details.
III.1.2)
Economic and financial standing
List and brief description of selection criteria:
Please see RFT document for further details.
Minimum level(s) of standards possibly required:
Please see RFT document for further details.
III.1.3)
Technical and professional ability
List and brief description of selection criteria:
Please see RFT document for further details.
Minimum level(s) of standards possibly required:
Please see RFT document for further details.
III.2)
Conditions related to the contract
III.2.2)
Contract performance conditions
Please see RFT document for further details.
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Open procedure
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)
Administrative information
IV.2.2)
Time limit for receipt of tenders or requests to participate
Date:
14/08/2020
Local time:
14:00
IV.2.4)
Languages in which tenders or requests to participate may be submitted
English
IV.2.6)
Minimum time frame during which the tenderer must maintain the tender
Duration in months
: 12
(from the date stated for receipt of tender)
IV.2.7)
Conditions for opening of tenders
Date:
14/08/2020
Local time:
14:00
Section VI: Complementary information
VI.1)
Information about recurrence
This is a recurrent procurement:
no
VI.4)
Procedures for review
VI.4.1)
Review body
Office of the High Court
Four Courts Ground Floor, Inns Quay
Dublin
7
IE
Telephone:
+353 18886000
E-mail:
HighCourtCentralOffice@courts.ie